Ensures ovarian cancer survivors have the right to access screenings for health conditions

This bill ensures that individuals with a history of ovarian cancer cannot be denied access to specific genetic and tumor profiling tests. It directly affects current and past ovarian cancer patients by guaranteeing their right to undergo these screenings without restrictions on how often they can be performed. The law mandates that health care providers cover testing for mutations in the BRCA1 and BRCA2 genes, Lynch syndrome, and other relevant genetic markers deemed medically necessary. By removing frequency caps and other limitations, the legislation aims to facilitate comprehensive health monitoring for this specific patient group.